Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Retained Earnings (2022 - 2025)

Gossamer Bio's Retained Earnings history spans 4 years, with the latest figure at -$1.4 billion for Q4 2025.

  • For Q4 2025, Retained Earnings fell 13.43% year-over-year to -$1.4 billion; the TTM value through Dec 2025 reached -$1.4 billion, down 13.43%, while the annual FY2025 figure was -$1.4 billion, 13.43% down from the prior year.
  • Retained Earnings reached -$1.4 billion in Q4 2025 per GOSS's latest filing, down from -$5.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$340000.0 in Q1 2022 to a low of -$1.4 billion in Q4 2025.
  • Average Retained Earnings over 4 years is -$902.2 million, with a median of -$1.1 billion recorded in 2023.
  • Peak YoY movement for Retained Earnings: skyrocketed 99.97% in 2023, then tumbled 362348.0% in 2024.
  • A 4-year view of Retained Earnings shows it stood at -$1.0 billion in 2022, then surged by 99.97% to -$350000.0 in 2023, then crashed by 362348.0% to -$1.3 billion in 2024, then decreased by 13.43% to -$1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Retained Earnings are -$1.4 billion (Q4 2025), -$5.1 million (Q3 2025), and -$1.3 billion (Q2 2025).